Nuwellis, Inc.
NUWE · Healthcare · $68,229
After-hours $0.74-0.79%
Price
$3.14
$0.75
Jul 1, 26Sep 29, 26
What's this stock's score right now?
See its score for free — revenue and money flow, graded on one standard.
Quarterly Financials
RevenueOperating IncomeNet Income
9/'26
Revenue$3M+27.2%
6/'26 vs prev quarter
Company Health
Market Cap$68,229
Operating Margin-140.6%
Cash on Hand$4M5748.3% of market cap
Free Cash Flow$-13M-18451.1% of market cap
Among 114 Medical - Devices peers
LowMedianHigh
PSR0.0xmedian 2.3xROE+541.1%median -26.3%Nuwellis Strengthens Product Development Organization with Appointment of Dale Brady as Principal R&D EngineerAug 6
Nuwellis Announces Next-Generation Aquadex Platform Strategy to Expand Future Critical Care ApplicationsAug 4
Nuwellis Announces Pricing of $3.4 Million Registered Direct Offering Priced At-The-Market Under Nasdaq RulesJul 31
Nuwellis Announces Acceptance by Frontiers in Pediatrics of New Single-Center Retrospective Study Supporting Alternative Anticoagulation Strategy for Aquadex Ultrafiltration TherapyJul 30
Nuwellis Expands Pediatric Footprint with First Aquadex SmartFlow® Installations in WisconsinJul 28
Nuwellis Announces Preliminary Revenue Results for the Second Quarter 2026 Showing Double Digit GrowthJul 27
